Communiqués Avantor, Inc.

Actions

AVTR

US05352A1007

Equipement, fournitures et distribution médicale

Temps réel estimé Cboe BZX 20:38:42 31/08/2026			Varia. 5j.	Varia. 1 janv.
14,44 ^USD	-0,99%		+0,83%	+27,23%

27/08	Avantor, Inc. annonce le départ de Benoit Gourdier, vice-président exécutif des produits Bioscience et Medtech, effectif au 14 octobre 2026	CI
30/07	Avantor, Inc. : Deutsche Bank Securities confirme sa recommandation neutre	ZM

Communiqués

29/07	Avantor® Reports Second Quarter 2026 Results	PR
14/07	Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product	PR
05/07	Avantor India Appointed as Exclusive Distributor for Sartorius Filter Papers to Serve India's Laboratory Consumables Sector	AQ
01/07	Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026	PR
19/05	Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory	PR
29/04	Avantor : 2026 Q1 Earnings Presentation	PU
29/04	Avantor : 2026 Q1 Earnings Supplemental	PU
29/04	Avantor® Reports First Quarter 2026 Results	PR
24/04	Avantor(R) Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer	AQ
23/04	Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer	PR
22/04	Avantor(R) Unifies Masterflex(R) Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing	AQ
21/04	Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing	PR
14/04	Avantor(R) Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility	AQ
14/04	Avantor India Expands its Strategic Collaboration with Parafilm to Serve the Indian Laboratory Consumables Market	AQ
13/04	Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility	PR
06/04	Avantor(R) to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026	AQ
03/04	Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026	PR
01/04	Avantor® Announces CFO Transition	PR
12/03	Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Avantor, Inc. (AVTR), Baxter International Inc. (BAX), Biogen Inc. (BIIB), and CarMax, Inc. (KMX)	AQ
11/02	Avantor : 2025 Q4 Earnings Presentation	PU
11/02	Avantor : 2025 Q4 Earnings Supplemental	PU
11/02	Avantor® Reports Fourth Quarter and Full Year 2025 Results	PR
28/01	Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm	PR
15/01	Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm	NE
14/01	P-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor	AQ